asthma
chronic
respiratori
diseas
associ
airway
inflamm
diseas
affect
approxim
million
peopl
worldwid
preval
increas
accord
latest
world
health
organ
estim
releas
decemb
asthmarel
death
death
occur
lowand
middleincom
countri
exacerb
play
import
role
asthma
morbid
mortal
exacerb
defin
acut
subacut
episod
progress
worsen
respiratori
symptom
sever
exacerb
correspond
emerg
consult
hospit
asthma
increasingli
common
caus
emerg
depart
consult
twenti
percent
patient
asthma
experienc
exacerb
requir
treatment
within
emerg
depart
hospit
patient
account
total
direct
cost
asthma
mortal
among
patient
hospit
asthma
exacerb
account
onethird
asthmarel
death
abbrevi
use
copdchron
obstruct
pulmonari
diseas
infect
pulmonari
tropism
frequent
involv
trigger
asthma
exacerb
case
often
associ
failur
convent
treatment
patient
asthma
rhinoviru
human
metapneumoviru
enteroviru
coronaviru
respiratori
syncyti
viru
common
virus
found
asthma
exacerb
rhinoviru
particularli
relat
asthma
exacerb
found
children
experienc
asthma
exacerb
adult
rhinoviru
also
seem
frequent
involv
asthma
exacerb
regard
virusinduc
asthma
exacerb
antivir
respons
complex
involv
immun
cell
lead
releas
inflammatori
mediat
immunoglobulin
play
key
role
antivir
respons
knowledg
remain
limit
involv
virusinduc
asthma
exacerb
interestingli
recent
shown
patient
primari
hypogammaglobulinemia
like
suffer
viral
infect
includ
rhinoviru
compar
healthi
subject
spite
intraven
immunoglobulin
replac
preval
asthma
appear
higher
patient
variou
immun
defici
includ
hypogammaglobulinemia
estim
preval
studi
mechan
caus
increas
preval
viral
infect
patient
hypogammaglobulinemia
unknown
secretori
iga
defici
bronchial
mucosa
suggest
knowledg
link
viral
infect
serum
immunoglobulin
patient
asthma
poorli
understood
purpos
project
compar
serum
igg
concentr
patient
upper
airway
specimen
test
posit
viru
neg
viral
specimen
time
hospit
asthma
exacerb
observ
studi
conduct
januari
decemb
patient
asthma
recruit
depart
respiratori
medicin
univers
hospit
tour
locat
center
franc
well
depart
respiratori
medicin
univers
centr
reunion
french
island
locat
indian
ocean
socioeconom
status
patient
close
locat
manag
way
french
govern
inclus
criteria
patient
age
year
older
hospit
asthma
exacerb
exacerb
defin
increas
respiratori
symptom
hour
use
oral
corticosteroid
therapi
asthma
diagnos
establish
histori
respiratori
symptom
wheez
short
breath
chest
tight
cough
associ
variabl
expiratori
airflow
limit
hospit
accord
global
initi
asthma
exclus
criteria
smoke
pack
cigarett
year
chronic
obstruct
pulmonari
diseas
copd
pregnanc
studi
approv
institut
review
board
de
pneumologi
de
langu
patient
gave
inform
written
consent
take
part
studi
demograph
data
age
sex
bodi
mass
index
smoke
statu
quantifi
pack
per
year
pa
inhal
treatment
prescrib
exacerb
well
use
durat
oral
steroid
exacerb
collect
total
serum
ige
concentr
immunoassay
techniqu
immunocap
ige
total
thermo
fisher
scientif
phadia
ab
uppsala
sweden
blood
eosinophilia
beckman
coulter
lh
control
analyz
creactiv
protein
beckman
coulter
lh
control
analyz
holliston
mass
also
collect
sever
exacerb
character
length
hospit
stay
includ
time
spent
emerg
room
patient
need
treat
intens
care
unit
control
asthma
defin
asthma
control
test
score
greater
equal
point
month
preced
consult
patient
receiv
followup
visit
month
exacerb
function
respiratori
test
perform
via
flowvolum
curv
use
plethysmograph
sensormed
vmax
encor
carefus
san
diego
calif
valu
forc
vital
capac
fev
express
percentag
predict
valu
accord
age
sex
weight
height
airway
obstruct
defin
postbronchodil
fev
forc
vital
capac
ratio
less
measur
taken
accord
atser
recommend
use
predict
valu
publish
er
prick
test
aeroallergen
hous
dust
mite
dermatophagoid
pteronyssinu
dermatophagoid
farina
site
blomia
tropicali
reunion
mold
alternaria
alternata
anim
dander
cat
dog
cockroach
blattella
germanica
tree
pollen
oliv
tree
birch
herbac
plant
ragwe
ambrosia
wormwood
grass
also
carri
quantit
data
normal
distribut
express
mean
sd
quantit
data
normal
distribut
express
median
deviat
interquartil
rang
qualit
data
express
frequenc
student
test
parametr
use
compar
continu
variabl
normal
distribut
mannwhitney
test
use
quantit
data
normal
distribut
statist
signific
defin
p
valu
less
receiv
oper
characterist
curv
use
assess
serum
igg
concentr
potenti
marker
posit
viru
specimen
best
igg
cutoff
determin
use
youden
index
sensit
specif
igg
cutoff
posit
viru
sampl
also
defin
spearman
test
use
assess
correl
serum
igg
concentr
continu
variabl
linear
relat
test
use
linear
regress
statist
analysi
carri
use
graph
pad
prism
softwar
licens
refer
eightytwo
patient
includ
studi
patient
characterist
summar
tabl
median
age
year
patient
predominantli
femal
overweight
median
bodi
mass
index
kgm
inhal
corticosteroid
treatment
use
patient
asthma
exacerb
patient
requir
intens
care
time
exacerb
median
durat
oral
corticosteroid
therapi
median
length
stay
exacerb
day
day
respect
nasopharyng
aspir
posit
virus
patient
common
virus
rhinoviru
myxoviru
influenza
metapneumoviru
enteroviru
figur
patient
posit
neg
viral
sampl
show
statist
signific
differ
term
demograph
biolog
data
tabl
ii
patient
posit
nasopharyng
aspir
virus
slightli
younger
patient
neg
nasopharyng
aspir
virus
vs
year
respect
statist
signific
p
patient
posit
viral
specimen
also
seem
hospit
intens
care
unit
often
compar
patient
harbor
neg
viral
specimen
vs
respect
howev
differ
signific
patient
posit
viral
sampl
significantli
lower
serum
igg
concentr
patient
host
neg
viral
specimen
ae
gl
vs
ae
gl
p
tabl
iii
differ
found
serum
iga
igm
concentr
group
igg
subclass
similar
group
invers
correl
observ
age
serum
igg
concentr
p
correl
shown
demograph
characterist
receiv
oper
characterist
curv
analyz
serum
igg
concentr
marker
predict
specimen
posit
viru
present
figur
accord
youden
index
best
cutoff
valu
serum
igg
predict
posit
viru
sampl
gl
optim
sensit
specif
respect
median
serum
concentr
igg
significantli
lower
patient
hospit
day
whose
hospit
stay
less
equal
day
gl
vs
gl
p
figur
b
patient
receiv
oral
corticosteroid
day
lower
median
serum
igg
concentr
patient
given
corticosteroid
therapi
day
less
gl
vs
gl
respect
p
figur
c
median
serum
concentr
igg
significantli
differ
patient
hospit
intens
care
unit
figur
invers
correl
observ
length
stay
serum
j
allergi
clin
immunol
pract
volum
number
igg
concentr
p
spearman
test
figur
correl
found
oral
steroid
serum
igg
concentr
receiv
oper
characterist
curv
creat
accord
length
stay
steroid
durat
know
reliabl
serum
igg
concentr
predict
biomark
exacerb
sever
length
stay
predict
day
day
best
sensit
specif
igg
concentr
respect
cutoff
valu
gl
see
figur
articl
onlin
repositori
wwwjaciinpracticeorg
regard
steroid
durat
predict
day
day
cutoff
valu
gl
best
sensit
specif
igg
concentr
respect
figur
posit
viru
sampl
combin
igg
serum
concentr
cutoff
gl
best
sensit
specif
length
stay
predict
respect
regard
cutoff
gl
best
sensit
specif
steroid
durat
predict
respect
figur
patient
asthma
posit
nasopharyng
viral
sampl
lower
serum
igg
concentr
time
exacerb
neg
viral
sampl
moreov
median
serum
igg
concentr
lower
patient
hospit
day
well
given
oral
steroid
day
compar
counterpart
studi
epidemiolog
virus
found
patient
hospit
asthma
exacerb
similar
data
observ
literatur
inde
herein
rhinoviru
frequent
observ
pathogen
viru
known
often
associ
asthma
exacerb
children
work
suggest
also
incrimin
viru
sever
asthma
exacerb
adult
patient
also
present
virus
myxoviru
influenza
myxoviru
influenza
particularli
influenza
respons
signific
morbid
mortal
patient
asthma
enteroviru
appear
less
frequent
found
literatur
cohort
enteroviru
alway
found
coinfect
rhinoviru
repres
patient
coinfect
remain
patient
coinfect
rhinovirusmyxoviru
influenza
n
metapneumoviru
bmyxoviru
influenza
n
adenovirusmyxoviru
influenza
n
coronaviru
influenza
n
relationship
coinfect
serum
igg
concentr
sever
exacerb
found
demograph
differ
found
patient
posit
viru
sampl
neg
viru
sampl
howev
although
differ
statist
signific
patient
posit
viru
sampl
slightli
younger
compar
neg
counterpart
vs
year
respect
lack
signific
probabl
due
small
sampl
size
well
known
asthma
exacerb
young
peopl
associ
viru
infect
bodi
mass
index
appear
bit
higher
patient
posit
viru
sampl
compar
patient
neg
viru
sampl
kgm
vs
kgm
respect
differ
also
signific
risk
viral
infect
obes
patient
asthma
identifi
elsewher
literatur
inde
asthma
obes
found
independ
risk
factor
pandem
influenza
hospit
studi
patient
posit
viru
group
requir
intens
care
although
signific
differ
data
literatur
suggest
respiratori
virus
may
trigger
sever
asthma
exacerb
particularli
young
peopl
link
viral
infect
asthma
exacerb
wide
recogn
impair
viral
immun
may
partli
explain
develop
viral
infect
patient
asthma
influenza
infect
igg
identifi
particularli
involv
protect
respiratori
tract
virus
role
seem
superior
iga
rhinovirusspecif
igg
appear
prevent
control
reinfect
high
concentr
specif
igg
antibodi
correl
attenu
respiratori
symptom
reduct
viral
shed
decreas
specif
viral
antibodi
patient
asthma
suggest
howev
anoth
studi
higher
antibodi
respons
rhinoviru
shown
patient
asthma
compar
control
without
asthma
given
studi
conduct
johnston
et
al
rhinoviru
involv
asthma
exacerb
children
may
also
specul
admit
patient
less
exposur
schoolag
children
past
therefor
gener
suffici
antibodi
respons
current
viru
es
mechan
beyond
adapt
immun
dysfunct
involv
virusinduc
asthma
exacerb
inde
alter
innat
immun
antivir
respons
observ
patient
asthma
compar
without
asthma
studi
add
mechanist
explan
low
level
serum
igg
patient
posit
viru
sampl
result
may
suggest
serum
igg
concentr
time
asthma
exacerb
would
marker
sever
inde
patient
hospit
length
day
steroid
cours
day
show
lower
igg
concentr
time
exacerb
among
patient
stabl
copd
reduc
total
igg
level
link
increas
risk
exacerb
hospit
studi
patient
serum
igg
level
less
gl
higher
risk
copd
exacerb
compar
patient
highest
quartil
serum
igg
assess
predict
abil
serum
igg
concentr
biomark
exacerb
sever
howev
seem
use
predictor
base
modest
sensit
poor
specif
combin
serum
igg
concentr
posit
viru
sampl
predict
exacerb
sever
improv
studi
need
specif
assess
igg
level
marker
sever
asthma
exacerb
predict
next
hospit
igg
level
would
also
interest
answer
question
studi
design
answer
question
howev
may
specul
low
igg
level
particularli
baselin
would
predispos
patient
viru
infect
consequ
increas
risk
hospit
studi
sever
limit
differ
igg
concentr
patient
posit
neg
viral
sampl
statist
signific
remain
uncertain
whether
differ
clinic
relev
robust
studi
role
igg
need
addit
chang
igg
concentr
immunoglobulin
time
assess
studi
measur
igg
patient
stabl
condit
would
interest
know
igg
declin
transient
longerlast
inde
patient
copd
low
igg
serum
concentr
baselin
seem
associ
sever
exacerb
per
year
howev
studi
viru
analysi
perform
final
studi
base
multiplex
pcr
viru
identif
nevertheless
list
virus
though
extens
exhaust
therefor
emerg
virus
rule
result
studi
show
serum
igg
level
significantli
lower
sever
asthma
exacerb
associ
posit
viral
sampl
serum
igg
level
lower
patient
longer
length
stay
cours
oral
steroid
prescrib
longer
durat
studi
request
know
exact
use
igg
concentr
sever
marker
sever
asthma
exacerb
understand
immunolog
mechan
viral
infect
sever
asthma
exacerb
may
interest
lead
develop
new
therapi
patient
sever
exacerb
sourc
signific
morbid
mortal
receiv
oper
characterist
curv
analysi
serum
igg
concentr
predict
length
stay
day
cutoff
valu
gl
best
sensit
specif
respect
b
predict
steroid
durat
day
cutoff
valu
gl
best
sensit
specif
respect
